Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aileron, Antibe, Belx, Biomarin, CTI, Gilead, GSK, Histogen, Iterum, Lineage Cell, Merck, Mesoblast, Moderna, Novartis, Novus, Ocugen, Pfizer, TLC.